Pulse Explorar nav.journalClub Debates Tendencias Investigadores

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Inicio Explorar nav.journalClub Tendencias

⌘+K

Evolving Issues in the Treatment of Depression | Synapse

May 24, 2019

Ver artículo completo

Evolving Issues in the Treatment of Depression

OKOle Köhler‐ForsbergHarvard University CCCristina CusinMassachusetts General Hospital ANAndrew A. NierenbergUniversity of Pisa

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

This Viewpoint discusses recent evidence documenting benefits of nonpharmacological and drug therapies for major depressive disorder including exercise, Mediterranean diet and structured dietary support, ketamine and esketamine, anti-inflammatory drugs, brexanolone, and psilocybin.

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Cite This Study

Köhler‐Forsberg et al. (Fri,) studied this question.

synapsesocial.com/papers/6a01c0480cec8eebbd5ca969 https://doi.org/https://doi.org/10.1001/jama.2019.4990

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Untitled2019 · 7 citations
2Association of Efficacy of Resistance Exercise Training With Depressive Symptoms2018 · 484 citations
3A Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders2017 · 577 citations
4Comparative Efficacy and Acceptability of 21 Antidepressant Drugs for the Acute Treatment of Adults With Major Depressive Disorder: A Systematic Review and Network Meta-Analysis2018 · 3,502 citations
5A Comprehensive Nationwide Study of the Incidence Rate and Lifetime Risk for Treated Mental Disorders2014 · 630 citations